Arm Holdings plc - American Depositary Shares (ARM)

Rocket Lab stock costs more than 80 times sales. It just bought a space subsidiary for maybe as little as 1.5 times sales.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Allogene Therapeutics (NASDAQ:ALLO) said its first quarter of 2026 was marked by early clinical progress for its lead allogeneic CAR-T programs and a strengthened cash position following an April financing. On the company’s quarterly conference call, President and Chief Executive Officer Dr. David

Allogene (ALLO) Q1 2026 Earnings Transcript

Ford’s new battery‑storage arm and a bullish Wall Street call are reshaping its growth story, today, May 13, 2026.

A larger total addressablea market may be a reason for optimism when it comes to Qualcomm.

Arm Holdings (ARM) jumps 5% as chip stocks rally. Investors eye US-China AI policy and Jensen Huang's Beijing visit. Read the latest.

NextEra Energy is well-positioned to dominate the renewables sector.

This semiconductor leader has added more than $1 trillion in market cap over the past year. There's likely more to come.

If the market shifts from “rate cuts” to “the world stays messy,” Nutrien could be a TSX winner tied to essential demand.

As AI data centers scale globally, Arm is helping run them while Fortinet is helping defend them.

Acumen (ABOS) Q1 2026 Earnings Transcript

Arm Holdings anticipates a significant surge in revenue and earnings over the next five years.

Cloudflare (NYSE:NET) reported a strong first quarter of 2026, with revenue rising 34% year over year to $639.8 million, as executives said demand tied to AI, agentic workloads and its Workers developer platform continued to accelerate. Co-founder and CEO Matthew Prince said the company began the y

AMD’s first quarter results were marked by significant growth in its data center segment and broad-based demand across all business units. Management credite...

Inhibrx Biosciences (NASDAQ:INBX) reported interim randomized Phase 2 data for INBRX-106 in combination with Merck’s KEYTRUDA in first-line PD-L1-positive head and neck squamous cell carcinoma, with Chief Executive Officer Mark Lappe saying the results showed a higher confirmed response rate and dee

The stock dropped after previously more than doubling on the year.

GoDaddy is showing mixed stock performance, but analysts remain broadly positive with stable sentiment and cautiously optimistic outlook intact.

EV stocks are chasing several multitrillion-dollar opportunities.

Palantir, Disney, Arm, Anthropic and Baidu drove a major market week with strong earnings, big deals and growth-focused moves.

This coin's problems are mounting, but they probably aren't the end.

Looking for a dividend stock that pays a solid yield and doesn't cost an arm and a leg? Look no further than VICI Properties.

Robotaxis have long been "around the corner," but they're finally gaining steam.

What Happened? A number of stocks jumped in the afternoon session after the semiconductor sector rose buoyed by robust AI-related demand and a strong global ...